Updates from Solventum
Solventum pioneers innovations in health, material, and data science to enable better, smarter, and safer healthcare for patients and professionals worldwide.
- Solventum Announces FDA 510(k) Clearance for Combined Use of Restrata™ Matrix and Solventum™ V.A.C.® Therapy* (Product launch · October 19, 2026)
Solventum received FDA 510(k) clearance to use its Restrata Synthetic Electrospun Fiber Matrix together with V.A.C. Therapy. - Solventum to Participate in the 2026 Wells Fargo Healthcare Conference (Event · September 2, 2026)
Solventum participated in the 2026 Wells Fargo Healthcare Conference to discuss its business and healthcare innovations. The event provided a platform for the company to engage with industry… - Solventum Completes Acquisition of Acera Surgical (Company update · December 23, 2025)
The deal expands Solventum's MedSurg portfolio with engineered materials for acute care settings.